 |
Deposito minimo $50 Promozione esclusiva |
Il nostro punteggio |
0% commissione |
Are you looking to buy Exact Sciences stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:EXAS! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Exact Sciences stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company’s pipeline products focuses on the research and development of enhancing Cologuard’s performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Volume medio
1,86 milioni di shs
TAPPA DEL MERCATO
$22.50 billion
Borsa valori
NASDAQ
Compri queste azioni!
|
NOME
|
TICKER
|
INDUSTRIA
|
SETTORE
|
VOLUME
|
COMPRI ORA QUESTE AZIONI
|
|---|---|---|---|---|---|
|
NASDAQ:EXAS
|
Commercial physical research
|
Medico
|
19,897 shs
|
Below is a quick guide on how to buy NASDAQ:EXAS stocks safe, fast and around the world in less than five minutes.
Passo 1: Aprire un conto con eToro – eToro is the best broker to buy Exact Sciences shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: caricare il suo ID - Come da regolamento KYC eToro le chiederà di caricare una copia del suo passaporto o della sua patente di guida.
Passo 3: Deposito di fondi - Depositi del denaro nel suo conto eToro appena creato. Può scegliere tra bonifico bancario, e-wallet o carta di debito/credito o Paypal.
Passo 4: Buy Exact Sciences – Search for “”NASDAQ:EXAS”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Exact Sciences stocks with 0% commission!.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
14 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Exact Sciences in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Exact Sciences stock.
Wall Street analysts have given Exact Sciences a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Exact Sciences wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
2 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
3 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:EXAS stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Exact Sciences stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Exact Sciences stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Poiché eToro è una piattaforma regolamentata, dovrà completare il processo KYC, questa è una pratica standard e richiede solo un paio di minuti. Dovrà fornire un documento d'identità con foto (passaporto, patente) e una prova di indirizzo (bolletta, estratto conto bancario).
Una volta iscritto e verificato il suo conto, dovrà depositare dei fondi. eToro accetta carte di credito/debito, trasferimenti bancari e anche portafogli elettronici. Quindi qualunque sia la sua preferenza ci sarà qualcosa per lei.
Now that you’ve funded your eToro account, just type “NASDAQ:EXAS stocks" nella barra di ricerca nella parte superiore dello schermo e prema "trade".
All that’s left is to buy some NASDAQ:EXAS stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:EXAS is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Exact Sciences stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Exact Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Exact Sciences.
Exact Sciences will be holding an earnings conference call on Tuesday, February 16th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Exact Sciences Co. (NASDAQ:EXAS) announced its quarterly earnings results on Sunday, November, 1st. The medical research company reported ($1.46) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.51) by $0.95. The medical research company had revenue of $408.40 million for the quarter, compared to analysts’ expectations of $337.43 million. Exact Sciences had a negative trailing twelve-month return on equity of 11.71% and a negative net margin of 25.27%. Exact Sciences’s revenue for the quarter was up 86.7% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.31) EPS.
View Exact Sciences’ earnings history.
Exact Sciences’ stock was trading at $57.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EXAS stock has increased by 152.5% and is now trading at $145.99.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:EXAS stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Oltre 95% dei fondi dei clienti sono tenuti offline, in depositi freddi, il che è fondamentale per qualsiasi broker che gestisce i suoi beni. Indipendentemente da quanto sia sicura una piattaforma, raccomandiamo di usare 2FA per aggiungere un ulteriore livello di sicurezza al suo conto.
eToro offre agli utenti una serie di caratteristiche per iniziare ad investire il più rapidamente possibile. Hanno una caratteristica relativamente unica chiamata copy trading, che le permette di guadagnare un reddito passivo facendo da specchio a trader esperti, questo le permette di iniziare a guadagnare rapidamente e le dà una migliore comprensione delle strategie usate dai professionisti. Inoltre, eToro permette agli utenti di investire in portafogli gestiti, un portafoglio gestito è una varietà di asset simili raggruppati insieme, che le permette di diversificare il suo conto, riducendo qualsiasi rischio potenziale. Per chi ha esperienza di trading precedente, può investire in mercati al di fuori delle azioni, dato che eToro permette agli utenti di commerciare ETF, materie prime, cripto e indici. Se già investe al di fuori dello spazio del mercato azionario questo può essere molto utile, perché le permette di gestire tutti i suoi investimenti in un solo posto.
14 brokers have issued 1-year price targets for Exact Sciences’ stock. Their forecasts range from $70.00 to $226.00. On average, they anticipate Exact Sciences’ stock price to reach $136.47 in the next year. This suggests that the stock has a possible downside of 6.5%.
View analysts’ price targets for Exact Sciences or view top-rated stocks among Wall Street analysts.
Exact Sciences’ management team includes the following people:
Mr. Kevin T. Conroy, Chairman, Pres & CEO (Age 55, Pay $1.82M)
Mr. Jeffrey T. Elliott CFA, Chief Financial Officer (Age 43, Pay $701.77k)
Ms. Ana Hooker, Sr. VP of Operations (Age 55, Pay $627.49k)
Mr. D. Scott Coward, Chief Admin. Officer, Sr. VP, Gen. Counsel & Sec. (Age 56, Pay $741.87k)
Mr. Mark Stenhouse, Advisor (Age 53, Pay $1.22M)
Mr. Jake Orville, Sr. VP of Pipeline (Age 47, Pay $769.63k)
Mr. G. Bradley Cole, Gen. Mang. of Precision Oncology (Age 65, Pay $1.23M)
Mr. Gary Frings, Chief Information Officer
Dr. Scott C. Johnson Ph.D., Chief Science Officer and Sr. VP of R&D
Ms. Megan Jones, Associate Mang. of Investor Relations
I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva. Il 68% dei conti degli investitori al dettaglio perdono denaro quando scambiano CFD con questo fornitore. Deve considerare se capisce come funzionano i CFD e se può permettersi di correre l'alto rischio di perdere i suoi soldi.
141 employees have rated Exact Sciences CEO Kevin T. Conroy on Glassdoor.com. Kevin T. Conroy has an approval rating of 97% among Exact Sciences’ employees. This puts Kevin T. Conroy in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to Exact Sciences include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR).
View all of EXAS’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Exact Sciences investors own include Novavax (NVAX), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), salesforce.com (CRM), PayPal (PYPL), Square (SQ), Advanced Micro Devices (AMD), The Walt Disney (DIS) and AbbVie (ABBV).
Exact Sciences trades on the NASDAQ under the ticker symbol “EXAS.”
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
Exact Sciences’ stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (1.22%), Frontier Capital Management Co. LLC (0.77%), First Trust Advisors LP (0.69%), Swiss National Bank (0.40%), Victory Capital Management Inc. (0.38%) and California Public Employees Retirement System (0.22%). Company insiders that own Exact Sciences stock include G Bradley Cole, Jacob A Orville, James Edward Doyle, Jeffrey Thomas Elliott, Katherine S Zanotti, Kevin T Conroy, Mark Stenhouse, Scott C Johnson and Torsten Hoof.
View institutional ownership trends for Exact Sciences.
EXAS stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, C WorldWide Group Holding A S, Gateway Investment Advisers LLC, Thompson Investment Management Inc., American National Bank, Creative Planning, Handelsinvest Investeringsforvaltning, and SVA Wealth Management LLC. Company insiders that have sold Exact Sciences company stock in the last year include Jacob A Orville, James Edward Doyle, Jeffrey Thomas Elliott, Katherine S Zanotti, Kevin T Conroy, Mark Stenhouse, and Torsten Hoof.
View insider buying and selling activity for Exact Sciences or view top insider-selling stocks.
EXAS stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Columbus Circle Investors, Victory Capital Management Inc., State of Michigan Retirement System, First Trust Advisors LP, Assenagon Asset Management S.A., Peregrine Capital Management LLC, and Delta Investment Management LLC.
View insider buying and selling activity for Exact Sciences or or view top insider-buying stocks.
Shares of EXAS can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Recensione di Interactive Brokers, Recensione di eToro, Recensione di DEGiro, Recensione di AvaTrade, Recensione di IG Markets, Rassegna dei mercati IC, Recensione di CMC Markets, Recensione di Admiral Markets e molti altri. Legga una delle recensioni per scoprire tutto sul broker e inizi a comprare azioni ora.
One share of EXAS stock can currently be purchased for approximately $145.99.
Exact Sciences has a market capitalization of $21.96 billion and generates $876.29 million in revenue each year. The medical research company earns $-83,990,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis.
A Reportlab.org vogliamo assicurarci che lei abbia tutte le informazioni più rilevanti su acquisto di azioni. Le portiamo le migliori guide sul mercato azionario con recensioni personali, informazioni di base, recensioni di piattaforme, how to's e altro. Vuole ottenere altre informazioni? Allora dia un'occhiata al Azioni OTC, Azioni del NASDAQ, Azioni del NYSE, Azioni LON, Scorte FRA, Azioni ETR, Scorte dell'EPA, Azioni del TSX o Azioni Amex. Cercando informazioni più dettagliate come 5g stock, azioni biotecnologiche, azioni d'oro e altre informazioni dal nostro reportlab.
How can you buy Exact Sciences stock on the internet?
You can easily buy Exact Sciences stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Un'altra opzione è usare un broker regolamentato come Mercati IC o Brokers interattivi. You can an account with these brokers and start buying or trading NASDAQ:EXAS stocks in a safe and complete environment to trade in.
Where to buy Exact Sciences stock?
You will first want to find a licensed broker that supports NASDAQ:EXAS stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:EXAS stocks in a safe and complete environment.
Is NASDAQ:EXAS stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:EXAS stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Exact Sciences stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:EXAS is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Exact Sciences stock.
How do you trade Exact Sciences stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Exact Sciences stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:EXAS stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Exact Sciences stock?
To sell your NASDAQ:EXAS stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Exact Sciences stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:EXAS stock.
Stephen conosce molto bene i prodotti finanziari e in particolare ha una grande passione per i mercati azionari e i suoi partecipanti. Speriamo che le informazioni fornite le siano utili. C'è qualcosa di poco chiaro? Lasci le sue domande o commenti in fondo alla pagina.
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ |
Notiziario
Notizie recenti
| |
Il nostro punteggio |
0% commissione |
Top 10 5G stocks Maggiori informazioni 5G stocks top 10 Best 5G Stock To Buy
Dati in tempo reale su azioni e criptovalute
Notifiche, Consigli e Notizie
Le migliori guide su azioni e criptovalute
Recensioni su broker e scambi online
Reportlab Finanza è un sito web puramente informativo e non implica in nessun caso consigli di investimento. Tutti gli investimenti comportano rischi e lei può perdere tutti i suoi investimenti. Non investa denaro che non può permettersi di perdere.
Reportlab Finanza
38 Holburn Lane
Heckfield Green
IP21 0UB
Regno Unito
Copyright © 2022 Reportlab.Finance | Tutti i diritti riservati.
